Long-term survivors in metastatic lung cancer study
Part of Cancer, Lungs & breathing clinical trials.
This study looks at people who have lived more than three years with advanced lung cancer (non-small cell or small cell) that has spread. The goal is to better understand why some people do well for a long time and how to help more patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been living with stage IV or stage III non-small cell or small cell lung cancer for more than three years
- You are not currently receiving chemotherapy (you may be on immunotherapy, targeted therapy, or just being watched)
- You are covered by the French National Health Insurance or private health insurance
- You can understand and answer questions in French
- You are able to give permission to collect your data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with hard-to-treat cancers live much longer than expected. It collects tumor samples to search for clues that might help future patients.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This study follows patients over time to see how anticancer treatments affect their quality of life. It's for adults who receive special cancer drugs and also get other support at the Rafael Institute.
This study looks at patients with advanced non-small cell lung cancer who received immunotherapy (immune checkpoint inhibitors) alone or in combination with other treatments. It aims to understand why some patients survive longer than others by analyzing their medical data and using AI to predict outcomes.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
This study follows people with lung cancer over time to see how the disease changes, especially during and after treatment. By collecting tumor samples and blood tests every few months, researchers hope to understand why some cancers come back or become resistant, and find better ways to treat them.
Hear when a new Metastatic Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.